ID FHL2_MOUSE Reviewed; 279 AA. AC O70433; P97448; DT 30-MAY-2000, integrated into UniProtKB/Swiss-Prot. DT 01-AUG-1998, sequence version 1. DT 27-MAR-2024, entry version 175. DE RecName: Full=Four and a half LIM domains protein 2; DE Short=FHL-2; DE AltName: Full=Skeletal muscle LIM-protein 3; DE Short=SLIM-3; GN Name=Fhl2; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC STRAIN=C57BL/6J; TISSUE=Brain; RA Chan K.K., Tsui S.K.W., Lee C.Y., Fung K.P., Waye M.M.Y.; RT "The cloning, sequencing and characterization of a mouse FHL2, which RT contains four and a half LIM domains."; RL Submitted (MAR-1998) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Skeletal muscle; RX PubMed=10049693; DOI=10.1006/bbrc.1999.0179; RA Morgan M.J., Madgwick A.J.A.; RT "The LIM proteins FHL1 and FHL3 are expressed differently in skeletal RT muscle."; RL Biochem. Biophys. Res. Commun. 255:245-250(1999). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY. RX PubMed=10906474; DOI=10.1016/s0925-4773(00)00341-5; RA Chu P.-H., Ruiz-Lozano P., Zhou Q., Cai C., Chen J.; RT "Expression patterns of FHL/SLIM family members suggest important RT functional roles in skeletal muscle and cardiovascular system."; RL Mech. Dev. 95:259-265(2000). RN [4] RP NUCLEOTIDE SEQUENCE [MRNA]. RC STRAIN=BALB/cJ; RA Starzinski-Powitz A., Martin B., Eckerdt F.; RT "Isolation of the mouse homolog mDRAL from skeletal muscle derived RT myoblasts."; RL Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases. RN [5] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain, Heart, Kidney, and Testis; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [6] RP SUBCELLULAR LOCATION, AND INTERACTION WITH FOXK1. RX PubMed=20013826; DOI=10.1002/stem.274; RA Shi X., Bowlin K.M., Garry D.J.; RT "Fhl2 interacts with Foxk1 and corepresses Foxo4 activity in myogenic RT progenitors."; RL Stem Cells 28:462-469(2010). RN [7] RP FUNCTION, INDUCTION, INTERACTION WITH CALCINEURIN, AND SUBCELLULAR RP LOCATION. RX PubMed=22851699; DOI=10.1128/mcb.05948-11; RA Hojayev B., Rothermel B.A., Gillette T.G., Hill J.A.; RT "FHL2 binds calcineurin and represses pathological cardiac growth."; RL Mol. Cell. Biol. 32:4025-4034(2012). CC -!- FUNCTION: May function as a molecular transmitter linking various CC signaling pathways to transcriptional regulation. Negatively regulates CC the transcriptional repressor E4F1 and may function in cell growth. CC Inhibits the transcriptional activity of FOXO1 and its apoptotic CC function by enhancing the interaction of FOXO1 with SIRT1 and FOXO1 CC deacetylation (By similarity). Negatively regulates the CC calcineurin/NFAT signaling pathway in cardiomyocytes (PubMed:22851699). CC {ECO:0000250|UniProtKB:Q14192, ECO:0000269|PubMed:22851699}. CC -!- SUBUNIT: Interacts with ZNF638 and TTN/titin. Interacts with E4F1. CC Interacts with GRB7. Interacts with SIRT1 and FOXO1. Interacts with CC CEFIP (By similarity). Interacts with calcineurin (PubMed:22851699). CC Interacts with FOXK1 (PubMed:20013826). {ECO:0000250|UniProtKB:Q14192, CC ECO:0000269|PubMed:20013826, ECO:0000269|PubMed:22851699}. CC -!- INTERACTION: CC O70433; Q8CIH5: Plcg2; NbExp=3; IntAct=EBI-299379, EBI-617954; CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q14192}. Nucleus CC {ECO:0000269|PubMed:20013826}. Cytoplasm, myofibril, sarcomere, Z line CC {ECO:0000269|PubMed:22851699}. CC -!- TISSUE SPECIFICITY: Highly expressed in heart but also detectable in CC brain and skeletal muscle. {ECO:0000269|PubMed:10906474}. CC -!- INDUCTION: Up-regulated in hearts exposed to isoproterenol (at protein CC level). {ECO:0000269|PubMed:22851699}. CC -!- DOMAIN: The third LIM zinc-binding mediates interaction with E4F1. CC {ECO:0000250|UniProtKB:Q14192}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF055889; AAC12770.1; -; mRNA. DR EMBL; U77040; AAB19211.2; -; mRNA. DR EMBL; AF114381; AAD53230.1; -; mRNA. DR EMBL; AF153340; AAD34170.1; -; mRNA. DR CCDS; CCDS14922.1; -. DR RefSeq; NP_001276462.1; NM_001289533.1. DR RefSeq; NP_034342.1; NM_010212.4. DR RefSeq; XP_011236736.1; XM_011238434.2. DR AlphaFoldDB; O70433; -. DR SMR; O70433; -. DR BioGRID; 199669; 10. DR IntAct; O70433; 6. DR MINT; O70433; -. DR STRING; 10090.ENSMUSP00000008280; -. DR GlyGen; O70433; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; O70433; -. DR PhosphoSitePlus; O70433; -. DR SwissPalm; O70433; -. DR EPD; O70433; -. DR jPOST; O70433; -. DR PaxDb; 10090-ENSMUSP00000008280; -. DR PeptideAtlas; O70433; -. DR ProteomicsDB; 270988; -. DR Pumba; O70433; -. DR Antibodypedia; 949; 408 antibodies from 38 providers. DR DNASU; 14200; -. DR Ensembl; ENSMUST00000008280.14; ENSMUSP00000008280.8; ENSMUSG00000008136.15. DR Ensembl; ENSMUST00000185893.2; ENSMUSP00000141170.2; ENSMUSG00000008136.15. DR GeneID; 14200; -. DR KEGG; mmu:14200; -. DR UCSC; uc007avk.2; mouse. DR AGR; MGI:1338762; -. DR CTD; 2274; -. DR MGI; MGI:1338762; Fhl2. DR VEuPathDB; HostDB:ENSMUSG00000008136; -. DR eggNOG; KOG1704; Eukaryota. DR GeneTree; ENSGT00950000183028; -. DR HOGENOM; CLU_001357_2_0_1; -. DR InParanoid; O70433; -. DR OMA; CAKCYED; -. DR OrthoDB; 370973at2759; -. DR PhylomeDB; O70433; -. DR TreeFam; TF321684; -. DR BioGRID-ORCS; 14200; 2 hits in 79 CRISPR screens. DR ChiTaRS; Fhl2; mouse. DR PRO; PR:O70433; -. DR Proteomes; UP000000589; Chromosome 1. DR RNAct; O70433; Protein. DR Bgee; ENSMUSG00000008136; Expressed in heart right ventricle and 246 other cell types or tissues. DR ExpressionAtlas; O70433; baseline and differential. DR GO; GO:0031430; C:M band; ISO:MGI. DR GO; GO:0005634; C:nucleus; IDA:MGI. DR GO; GO:0030018; C:Z disc; IDA:UniProtKB. DR GO; GO:0043425; F:bHLH transcription factor binding; IPI:BHF-UCL. DR GO; GO:0042802; F:identical protein binding; ISO:MGI. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0003712; F:transcription coregulator activity; IBA:GO_Central. DR GO; GO:0003714; F:transcription corepressor activity; IDA:BHF-UCL. DR GO; GO:0008134; F:transcription factor binding; ISS:UniProtKB. DR GO; GO:0055014; P:atrial cardiac muscle cell development; IEP:BHF-UCL. DR GO; GO:0060347; P:heart trabecula formation; IEP:BHF-UCL. DR GO; GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB. DR GO; GO:0070885; P:negative regulation of calcineurin-NFAT signaling cascade; IMP:UniProtKB. DR GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:BHF-UCL. DR GO; GO:0001649; P:osteoblast differentiation; IEP:BHF-UCL. DR GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IDA:MGI. DR GO; GO:0009725; P:response to hormone; ISO:MGI. DR GO; GO:0055015; P:ventricular cardiac muscle cell development; IEP:BHF-UCL. DR CDD; cd09433; LIM4_FHL2; 1. DR Gene3D; 2.10.110.10; Cysteine Rich Protein; 4. DR InterPro; IPR001781; Znf_LIM. DR PANTHER; PTHR24205; FOUR AND A HALF LIM DOMAINS PROTEIN; 1. DR PANTHER; PTHR24205:SF3; FOUR AND A HALF LIM DOMAINS PROTEIN 2; 1. DR Pfam; PF00412; LIM; 4. DR SMART; SM00132; LIM; 4. DR SUPFAM; SSF57716; Glucocorticoid receptor-like (DNA-binding domain); 5. DR PROSITE; PS00478; LIM_DOMAIN_1; 4. DR PROSITE; PS50023; LIM_DOMAIN_2; 4. DR Genevisible; O70433; MM. PE 1: Evidence at protein level; KW Cytoplasm; Isopeptide bond; LIM domain; Metal-binding; Nucleus; KW Phosphoprotein; Reference proteome; Repeat; Transcription; KW Transcription regulation; Ubl conjugation; Zinc; Zinc-finger. FT CHAIN 1..279 FT /note="Four and a half LIM domains protein 2" FT /id="PRO_0000075738" FT DOMAIN 40..92 FT /note="LIM zinc-binding 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00125" FT DOMAIN 101..153 FT /note="LIM zinc-binding 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00125" FT DOMAIN 162..212 FT /note="LIM zinc-binding 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00125" FT DOMAIN 221..275 FT /note="LIM zinc-binding 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00125" FT ZN_FING 7..31 FT /note="C4-type" FT /evidence="ECO:0000255" FT MOD_RES 238 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q14192" FT CROSSLNK 78 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0000250|UniProtKB:Q14192" FT CROSSLNK 167 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0000250|UniProtKB:Q14192" FT CROSSLNK 220 FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with FT G-Cter in SUMO2)" FT /evidence="ECO:0000250|UniProtKB:Q14192" SQ SEQUENCE 279 AA; 32073 MW; 6D8CBC4B4424BFF2 CRC64; MTERFDCHHC NESLYGKKYI LKEENPHCVA CFEELYANTC EECGTPIGCD CKDLSYKDRH WHEGCFHCSR CGSSLVDKPF AAKEEQLLCT DCYSNEYSSK CQECKKTIMP GTRKMEYKGS SWHETCFTCQ RCQQPIGTKS FIPKENQNFC VPCYEKQYAL QCVQCKKPIT TGGVTYREQP WHKECFVCTA CKKQLSGQRF TARDEFPYCL TCFCDLYAKK CAGCTNPISG LGGTKYISFE ERQWHNDCFN CKKCSLSLVG RGFLTERDDI LCPDCGKDI //